arrow
A

Alexandra L. Dima

Novartis
H指数:28
被引数:2,684

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

'We're not going to start lifting stones now…': Stakeholder perspectives on the role of psychometric methods in outcome measurement

“我们现在不会开始翻石头……”:利益相关者对心理测量方法在结果测量中作用的观点

2026-05-010
OAAI
SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancers

SALVOVAR:一项比较SALVage周剂量密集方案与标准3周方案在预后不良的OVARian癌患者中的务实随机III期试验

2025-12-230
PRE
Collecting behavioural data across countries during pandemics: Development of the COVID-19 Risk Assessment Tool

跨国家大流行期间收集行为数据:COVID-19风险评估工具的开发

2025-07-140
OA
Applying advanced psychometric approaches yields differential randomized trial effect sizes: secondary analysis of individual participant data from antidepressant studies using the Hamilton rating scale for depression

应用高级心理测量方法产生差异化的随机试验效应量:使用抑郁量表对抑郁评分的个体参与者数据来自抗抑郁药研究的二次分析

2025-07-010
OAAI
Medication adherence in the curricula of future European physicians, pharmacists and nurses - a cross-sectional survey

未来欧洲医师、药剂师和护士课程中的药物治疗依从性——一项横断面调查

2025-03-050
OA
Evaluating the psychometric structure of the Hamilton Rating Scale for Depression pre- and post-treatment in antidepressant randomised trials: Secondary analysis of 6843 individual participants from 20 trials

在抗抑郁药随机试验中评估汉密尔顿抑郁量表治疗前后的心理计量学结构: 来自20项试验的6843名个体参与者的二次分析

2024-09-011
OAAI
Stakeholder Consensus on an Interdisciplinary Terminology to Enable the Development and Uptake of Medication Adherence Technologies Across Health Systems: Web-Based Real-Time Delphi Study

利益相关者对跨学科术语的共识,以促进医疗系统间用药依从性技术的开发与采纳:一项基于网络的实时德尔菲研究

2024-04-280
OA
Evaluation of adherence to antipsychotics: A real-world data study using four different dosing assumptions

抗精神病药物依从性的评估: 使用四种不同剂量假设的真实数据研究

2024-03-182
PRE
Inhaler Technique Questionnaire (InTeQ) in pediatric patients with asthma
2023-03-063
OAAI